Akebia Therapeutics, Inc. (AKBA) Covered Calls
Akebia Therapeutics Inc is a biopharmaceutical company. It is engaged in the development of proprietary therapeutics based on hypoxia inducible factor, or HIF, biology and the commercialization of these products for patients with kidney disease.
You can sell covered calls on Akebia Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for AKBA (prices last updated Fri 4:16 PM ET):
| Akebia Therapeutics, Inc. (AKBA) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 3.68 | +0.12 | 3.60 | 3.68 | 7.8M | - | 0.9 |
| Covered Calls For Akebia Therapeutics, Inc. (AKBA) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Jul 18 | 2.5 | 1.00 | 2.68 | -6.7% | -84.3% | |
| Aug 15 | 2.5 | 0.60 | 3.08 | -18.8% | -120.4% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Akebia Therapeutics, Inc. is a biopharmaceutical company, which focuses on development of novel, proprietary therapeutics based on hypoxia-inducible factor biology and the commercialization of these products for patients with kidney disease. Its lead product candidate, AKB-6548, is in a Phase 2b clinical trial in patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. AKB-6548 is being developed as a once-daily oral therapy which works through the inhibition of hypoxia-inducible factor prolyl hydroxylase, leading to stabilization and increased levels of HIF and therefore improved production of hemoglobin and red blood cells. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
| Top 10 Open Interest For Jul 18 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | SLV covered calls | 6. | TSLA covered calls | 1. | ALT covered calls | |
| 2. | NVDA covered calls | 7. | IWM covered calls | 2. | COGT covered calls | |
| 3. | SPY covered calls | 8. | FXI covered calls | 3. | BBAI covered calls | |
| 4. | GLD covered calls | 9. | AAPL covered calls | 4. | RUN covered calls | |
| 5. | TLT covered calls | 10. | CLSK covered calls | 5. | CELC covered calls | |
Want more examples? AKAM Covered Calls | AKR Covered Calls
